CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial of pembrolizumab in metastatic non-squamous non-small cell lung cancer has completed, with results posted in October 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Joel Neal | Conditions: Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09